Filana Therapeutics, Inc.
FLNA· Nasdaq
FLNAFilana Therapeutics, Inc.
Filed May 8, 2025 · 10-Q · 38 days after period end · 0001437749-25-015478
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Net Income | -$23.40M | $25.04M | -$24.27M | -$17.53M |
| EPS Diluted | -$0.48 | -$0.43 | -$0.58 | -$0.44 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Filana Therapeutics, Inc. · CIK 1069530 · Engraved from SEC EDGAR
ended Mar 31, 2025 · filed May 8, 2025 · 38 d after period end
